Full-Time

Therapy Sales Representative

Confirmed live in the last 24 hours

Medtronic

Medtronic

10,001+ employees

Develops and manufactures medical devices and therapies

Biotechnology
Healthcare

Junior, Mid

Watford, UK

The role is accountable for driving sales and market share within the London area.

Category
Field Sales
Sales & Account Management
Required Skills
Sales

You match the following Medtronic's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Sales/commercial experience in healthcare (preferably neuromodulation or neurosurgery)
  • Scientific degree and clinical interests (preferred Neuroscience)
  • Strong organizational skills
  • Excellent communication and Influencing skills
  • Full Current UK Driving Licence
Responsibilities
  • Accountable for hitting set targets by focusing on driving Medtronic share in competitive accounts
  • Maintain / build / strengthen relationships with clinical / economic stakeholders
  • Provide and support to facilitate technology adoption and supports patient needs (e.g., programming). Perform trouble-shooting functions and resolve customer issues in key accounts
  • Effectively collaborate with technical, clinical and engineer teams to ensure best use and practices of our devices within key accounts
  • Ensure competitor knowledge remains up to date along with the ability to promote Medtronic products in line with clinician and service needs
  • Data monitoring
Desired Qualifications
  • Scientific degree and clinical interests (preferred Neuroscience)

Medtronic provides medical technology, services, and solutions to improve patient care. The company develops a variety of medical devices, including pacemakers, insulin pumps, surgical tools, and neurostimulation devices, which help diagnose, prevent, and treat chronic diseases. These products are used by hospitals and healthcare professionals around the world. Medtronic stands out from competitors by not only focusing on product development but also offering training, patient management programs, and technical support to healthcare providers. The goal of Medtronic is to enhance patient outcomes and lower healthcare costs through comprehensive solutions.

Company Size

10,001+

Company Stage

IPO

Total Funding

$3.2M

Headquarters

Fridley, Minnesota

Founded

1949

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI adoption in medical imaging boosts Medtronic's diagnostic device efficiency.
  • Telehealth growth expands opportunities for Medtronic's connected devices and solutions.
  • Personalized medicine trends drive demand for Medtronic's adaptive technologies like BrainSense™ aDBS.

What critics are saying

  • Stricter European regulations may delay Medtronic's product launches.
  • Rising competition in diabetes care from Dexcom and Abbott threatens market share.
  • Supply chain issues, especially in semiconductors, could disrupt Medtronic's device production.

What makes Medtronic unique

  • Medtronic's BrainSense™ aDBS offers personalized Parkinson's treatment, enhancing patient outcomes.
  • The company leads in minimally invasive surgical tools, meeting growing market demand.
  • Medtronic's global presence in over 150 countries strengthens its market reach and influence.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Company News

PR Newswire
Feb 18th, 2025
Medtronic Reports Third Quarter Fiscal 2025 Financial Results

Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and NeuromodulationGALWAY, Ireland, Feb. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025.Key Highlights

Surgical Robotics Technology
Feb 13th, 2025
Medtronic Acquires Certain Nano Surface Technology from Nanovis

Medtronic acquires certain nano surface technology from Nanovis.

Retia Medical
Feb 11th, 2025
Retia signs US distribution Agreement for Argos(R) Cardiac Output Monitor with Medtronic

WHITE PLAINS, NEW YORK, UNITED STATES, Febryary 11, 2025 - Retia Medical, an innovator in AI algorithms for patient monitoring and management, announced that it has entered into an agreement with Medtronic plc, a global leader in healthcare technology, to distribute the Argos Cardiac Output Monitor designed to provide healthcare professionals with highly accurate hemodynamic data to support the treatment of high-risk surgical and critically ill patients.

PR Newswire
Feb 5th, 2025
Medtronic To Announce Financial Results For Its Third Quarter Of Fiscal Year 2025

GALWAY, Ireland, Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2025, which ended on Friday, January 24, 2025. Medtronic will host a video webcast at 7:00 a.m

Stock Titan
Jan 21st, 2025
Medtronic appoints Thierry Piéton as Chief Financial Officer

GALWAY, Ireland, Jan. 21, 2025 /PRNewswire/ - Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for the company, effective March 3, 2025.